Back to directory
Ten63 Therapeutics

Ten63 Therapeutics

biotechDurhamseries_b
ten63tx.com

AI platform for cancer drug discovery

At a glance

  • Founded: 2018
  • HQ: Durham
  • Sector: Biotech
  • Stage: Series B
  • Total raised: $45M
  • Last round: Growth
  • Team size: 1-19
  • Affiliation: Duke

This is the free preview.

The full profile is for members: founders, funding history, investor connections, and recent signals. Accounts are free; I review every request, usually within 48 hours.